Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep 24:5:464.
doi: 10.3389/fimmu.2014.00464. eCollection 2014.

Toll-like receptors and cancer, particularly oral squamous cell carcinoma

Affiliations
Review

Toll-like receptors and cancer, particularly oral squamous cell carcinoma

Alison Mary Rich et al. Front Immunol. .

Abstract

It is becoming increasingly apparent that the tumor microenvironment plays an important role in the progression of cancer. The microenvironment may promote tumor cell survival and proliferation or, alternatively may induce tumor cell apoptosis. Toll-like receptors (TLRs) are transmembrane proteins, expressed on immune cells and epithelial cells, that recognize exogenous and endogenous macromolecules. Once activated, they initiate signaling pathways leading to the release of cytokines and chemokines, which recruit immune cells inducing further cytokine production, the production of angiogenic mediators and growth factors, all of which may influence tumor progression. This paper examines the actions of TLRs in carcinogenesis with particular emphasis on their role in oral squamous cell carcinoma.

Keywords: NF-κB; TLR; oral squamous cell carcinoma; toll-like receptors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagram showing how TLRs can mediate pro- and anti-tumor pathways.
Figure 2
Figure 2
Photomicrograph showing TLR2+ cells with a dusky red cell membrane and cytoplasmic staining (black arrow) with the morphology of macrophages in OSCC (ȕ100, bar: 100 μm).

References

    1. Baker BS, Ovigne J-M, Powles AV, Corcoran S, Fry L. Normal keratinocytes express toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol (2003) 148:670–910.1046/j.1365-2133.2003.05287.x - DOI - PubMed
    1. Sugawara Y, Uehara A, Fujimoto Y, Kusomoto S, Fukase K, Shibata K, et al. Toll-like receptors, NOD1 and NOD2 in oral epithelial cells. J Dent Res (2006) 85:524–910.1177/154405910608500609 - DOI - PubMed
    1. Carvalho FA, Aitken JD, Vijay-Kumar M, Gewirtz AT. Toll-like receptor-gut microbiota interactions:perturb at your own risk! Ann Rev Physiol (2012) 74:177–9810.1146/annurev-physiol-020911-153330 - DOI - PubMed
    1. Nasu K, Narahara H. Pattern recognition via the toll-like receptor system in the human female genital tract. Mediators Inflamm (2010) 2010:976024.10.1155/2010/976024 - DOI - PMC - PubMed
    1. Basith S, Manavalan B, Yoo TH, Kim SG, Choi S. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense. Arch Pharm Res (2012) 35:1297–31610.1007/s12272-012-0802-7 - DOI - PubMed

LinkOut - more resources